Intellia Therapeutics Inc
Change company Symbol lookup
Select an option...
NTLA Intellia Therapeutics Inc
MGNI Magnite Inc
INFN Infinera Corp
PRSRW Prospector Capital Equity Warrants 1st Jan 2025 *W EXP 01/01/2025
HYMCW Hycroft Mining Holding Equity Warrant Exp 29th May 2025 *W EXP 05/29/2025
NVOS Novo Integrated Sciences Inc
TEL TE Connectivity Ltd
NOTV Inotiv Inc
PLUG Plug Power Inc
WMT WALMART STORES INC
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Intellia Therapeutics, Inc. is a clinical-stage genome editing company, which is focused on developing curative therapeutics using Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) technology. CRISPR/Cas9 is a technology for genome editing, the process of altering selected sequences of genomic deoxyribonucleic acid. It is focused on leveraging its modular platform to advance in vivo and ex vivo therapies for diseases with high unmet need. Its lead in vivo candidate, NTLA-2001, is for the treatment of transthyretin (ATTR) amyloidosis, as well as NTLA-2002 for the treatment of hereditary angioedema (HAE). It is developing ex vivo applications to address immuno-oncology and autoimmune diseases. Its advanced ex vivo programs include a wholly owned chimeric antigen receptor T (CAR-T) cell candidate, NTLA-6001 targeting CD30 for the treatment of CD30-expressing hematologic cancers, including relapsed or refractory classical Hodgkin's lymphoma.

Closing Price
$43.62
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Average)
Volume:
990,362

10-day average volume:
999,395
990,362
  • Prev Close
    43.62
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    999.4K
  • Last (time)
    4:00p ET 06/06/23
  • Last (size)
    10
  • 52-Wk Range
    32.44 - 76.45
    LowHigh
  • (08/03/22 - 01/20/23)
    34.48%
  • 72.0%
  • Market Cap
    3.8B
  • Shares Outstanding
    88.1M
  • -5.39
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.8
  • 84.40
  • (% of float 05/15/23)
    7.12

Latest News

June 05, 2023
4:01 pm ET
Globe Newswire
May 31, 2023
7:30 am ET
Globe Newswire
May 04, 2023
7:30 am ET
Globe Newswire
May 03, 2023
4:35 pm ET
Zacks
May 01, 2023
7:30 am ET
Globe Newswire
April 27, 2023
7:30 am ET
Globe Newswire
April 17, 2023
4:01 pm ET
Globe Newswire
April 05, 2023
7:00 am ET
Globe Newswire
March 21, 2023
7:30 am ET
Globe Newswire
March 14, 2023
10:18 am ET
MarketWatch
March 02, 2023
8:09 am ET
MarketWatch
January 06, 2023
7:49 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.